🔥 HOT OF THE PRESSES 🔥 Looking @ benign & malignant foregut diseases. diff in healthcare delivery | how it impacts diagnoses, interventions, & outcomes for foregut diseases & biologic diff b/w sexes & races for various esophagogastric diseases. https://t.co/0FRmmPMewk
Just registered for the AFS Annual Meeting in Dallas! I’m looking forward to welcoming Foregut Folks from all around the world https://t.co/MvPUriUPEh #AFS2023#BetterTogether
🏆CALL FOR AFS AWARD NOMINATIONS 🏆 The AFS is seeking nominations for the 2023 awards.
Award recipients will be honored at the 2023 AFS Annual Meeting in September.
https://t.co/SJ0jyGX4NX
#AFS2023#BetterTogether
Endoscopic Treatment for Disease Persistence/Recurrence after Definitive Chemoradiotherapy for Esophageal Cancer
https://t.co/uBZzZ1u8mr @foregut_journal@EuropeanForegut
📢 SPOTLIGHT on Dr. Samil Sarıcı @SamilSarici_MD
presentations from @AHNtoday at @SSATNews annual meeting.
Join us in Chicago as he presents @AHNesophagus studies on surgical management of #EGJOO and delayed recurrence of symptoms after #MSA.